Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohmori, J.
Right arrow Articles by Murata, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohmori, J.
Right arrow Articles by Murata, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry, Vol. 47, 481-488, April 1999, Copyright © 1999, The Histochemical Society, Inc.


ARTICLE

Keratan Sulfate Glycosaminoglycans in Murine Eosinophil-specific Granules

Jun Ohmoria, Yukifumi Nawab, Dan-Ha Yanga, Shinichiro Tsuyamaa, and Fusayoshi Murataa
a Department of Anatomy, Kagoshima University, Faculty of Medicine, Sakuragaoka, Kagoshima
b Department of Parasitology, Miyazaki Medical College, Kiyotake, Miyazaki

Correspondence to: Jun Ohmori, Dept. of Anatomy, Kagoshima University, Faculty of Medicine, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.


*   Summary
*Top
*Summary
*Introduction
*Materials and Methods
*Results
*Discussion
*Literature Cited

We examined the presence of sialyl glycoconjugates in specific granules from murine bone marrow eosinophils. Lectin cytochemistry using Maackia amurensis lectin II (MAL II) specific for sialyl {alpha}-2,3 galactose residues demonstrated positive labeling in both immature and mature specific granules. Pretreatment with Clostridium neuraminidase or keratanase II eliminated the positive labeling of MAL II in the specific granules. High iron diamine–thiocarbohydrazide–silver proteinate physical development (HID-TCH-SP-PD) staining, which is specific for sulfated glycoconjugates, also positively labeled immature specific granules lacking crystalloids but not mature granules with crystalloids. Pretreatment with a combination of chondroitinase ABC and keratanase, or a combination of chondroitinase ABC and keratanase II, eliminated the positive labeling obtained with HID-TCH-SP-PD. These results indicate that the sialyl residues detected by MAL II are expressed as terminal sugar residues of keratan sulfate proteoglycan, which appears to be of the corneal type in view of its sensitivity to keratanase and keratanase II. (J Histochem Cytochem 47:481–488, 1999)

Key Words: keratan sulfate, acidic glycoconjugates, eosinophil-specific granules, mouse


*   Introduction
*Top
*Summary
*Introduction
*Materials and Methods
*Results
*Discussion
*Literature Cited

Eosinophils contain an abundance of specific granules. These granules exhibit acidophilia in late eosinophils of bone marrow and mature eosinophils of peripheral blood. This acidophilia is mainly due to highly basic granule proteins: eosinophil peroxidase, eosinophil cationic protein and eosinophil-derived neurotoxin in the matrix, and major basic protein in crystalloids (Venge 1993 Down). In contrast, staining with basic dyes at low pH has demonstrated the presence of strongly acidic substances in some eosinophil-specific granules (Dunn and Spicer 1969 Down). Since then, studies of acidic glycoconjugates in specific granules have been performed using various staining methods such as high iron diamine (HID) (Dunn and Spicer 1969 Down), antimonate–osmium tetroxide (Hardin and Spicer 1970 Down), dialyzed iron (Hardin and Spicer 1971 Down), HID–thiocarbohydrazide–silver proteinate (HID-TCH-SP) (Parmley et al. 1982 Down), low iron diamine–TCH-SP (Parmley et al. 1982 Down), and cationic colloidal gold (Yang et al. 1998 Down). In combination with enzyme degradation, these staining methods have demonstrated the presence of sulfated glycoconjugates in eosinophil-specific granules. The biochemical composition of sulfated glycosaminoglycans (GAGs) from human eosinophils has been shown to be chondroitin 4-sulfate, chondroitin 6-sulfate, and dermatan sulfate (Metcalfe et al. 1982 Down). The other type of acidic residue, sialyl residues, are relatively large, hydrophilic, and acidic molecules that have a considerable influence on the physicochemical features of the substances to which they are bound (Schauer et al. 1995 Down). They are widely distributed in tissues and play important biological roles (Rosenberg 1995 Down). This study was undertaken to examine whether sialyl glycoconjugates are expressed in murine eosinophil-specific granules.


*   Materials and Methods
*Top
*Summary
*Introduction
*Materials and Methods
*Results
*Discussion
*Literature Cited

Mice
Ten-week-old female (C57BL/6 x DAB/2) F1-BDF1, C57BL/6, and BALB/c mice were purchased from Japan SLC (Shizuoka, Japan).

Tissue Preparation
Bone marrow samples were fixed in half-strength Karnovsky's fixative composed of 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4 (PBS). They were then dehydrated in a graded ethanol series at -35C. After infiltration with Lowicryl K4M resin (Polysciences; Washington, PA), the specimens were placed in capsules with some fresh resin. Polymerization was performed initially at -35C for 24 hr and then at 20C for another 24 hr under indirect, diffuse UV irradiation using a low-temperature polymerization apparatus TTP 010 (Balzer Union; Lichtenstein). Ultrathin sections were cut with an Ultracut N (Reichert-Jung; Vienna, Austria) ultramicrotome and collected on Formvar-coated gold grids.

High Iron Diamine–Thiocarbohydrazide-Silver Proteinate Physical Development (HID-TCH-SP-PD) Staining (Table 1)
The specimens were stained for 18 hr at room temperature (RT) with a high iron diamine solution consisting of 1.6 ml 40% FeCl3, 120 mg N,N-dimethyl-m-phenylene-diamine-(HCl)2 (Sigma Chemical; St Louis, MO), and 20 mg N,N-dimethyl-p-phenylene-diamine-HCl (Sigma) in 50 ml distilled water, final pH 1.4. The grids were immersed in 1% thiocarbohydrazide (Sigma) in 20% acetic acid solution for 60 min at RT, washed serially with 10% and 5% acetic acid, and finally washed with distilled water. The sections were then stained with 1% silver proteinate (Merck; Darmstadt, Germany) solution for 60 min and finally developed with a physical developer IntenSE M kit (Amersham International; Poole, UK) for 3 min at RT. The sections were finally counterstained with 2% aqueous uranyl acetate for 3 min.


 
View this table:
[in this window]
[in a new window]
 
Table 1. Specificity of stainings and glycosidasesa

Lectin Staining (Table 1)
Ultrathin sections were incubated in PBS containing 1% BSA (PBS–BSA) for 30 min at RT. The sections were then incubated in biotinylated Maackia amurensis lectin II (MAL II) or Sambucus nigra (SAN) (Vector Laboratories; Burlingame, CA) lectin dissolved in PBS–BSA overnight at 4C. After two washes with PBS, the sections were incubated in 15-nm colloidal gold-labeled streptavidin (1:40) dissolved in PBS–BSA. The sections were then washed twice with PBS, stained with 2% uranyl acetate for 3 min, and then with Millonig's lead for 1 min at RT.

Enzyme Degradation (Table 1)
For neuraminidase treatment, ultrathin sections were treated with 1 U/ml Clostridium neuraminidase (Sigma) in 0.1 M acetate buffer (pH 5.0) with 0.04 M CaCl2 for 18 hr at 37C according to the method of Roth et al. 1984 Down. For keratanase II treatment, ultrathin sections were treated with 0.1 U/ml keratanase II (Seikagaku; Tokyo, Japan) in 0.05 M sodium acetate buffer (pH 6.5) for 18 hr at 37C according to the method of Ito et al. 1996 Down. For keratanase treatment, ultrathin sections were treated with 2 U/ml keratanase (Pseudomonas sp.) (Seikagaku) in 0.05 M Tris-HCl buffer (pH 7.4) for 18 hr at 37C according to a modification of the method of Nakazawa et al. 1975 Down and the manufacturer's protocol. For chondroitinase ABC (Seikagaku) treatment, ultrathin sections were treated with 2 U/ml protease-free chondroitinase ABC in 0.2 M Tris-HCl (pH 8.0) for 18 hr at 37C according to the method of Goode et al. 1991 Down. Control sections were incubated in the same buffer alone for the same period. Afterwards, sections were washed in distilled water three times for 10 min and then stained with MAL II lectin or HID-TCH-SP-PD as described above.

Electron Microscopy
Electron microscopic observation was performed with a Hitachi H-7000 transmission electron microscope at 75 kV accelerating voltage.

Morphometry
Morphometric analysis of colloidal gold labeling on the eosinophil-specific granules was performed using electron micrographs (magnification x15,000). We measured the areas of the granules and colloidal gold particles using NIH Image (Version 1.58) imaging software from the National Institutes of Health (Bethesda, MD) on a personal computer and calculated the labeling intensity of colloidal gold on the granules. The granules cut in the middle were randomly chosen and measured in approximately 50 cells.

Statistical Analysis
Differences among groups were analyzed statistically by the Mann–Whitney test.


*   Results
*Top
*Summary
*Introduction
*Materials and Methods
*Results
*Discussion
*Literature Cited

Expression of Sialyl {alpha}-2,3 Galactose Residues in Murine Eosinophil-specific Granules
To examine whether eosinophil-specific granules express sialyl glycoconjugates, we performed lectin cytochemistry with MAL II lectin specific for sialyl {alpha}-2,3 galactose or SAN lectin specific for sialyl {alpha}-2,6 galactose. MAL II lectin positively labeled immature and mature specific granules (Figure 1A and Figure 1B). The labeling was higher in mature granules than in immature granules (Table 2). The positive labeling was completely eliminated by pretreatment with Clostridium neuraminidase, not only in the specific granules but also other areas of eosinophils (Figure 1C). No labeling was observed with SAN lectin (not shown).



View larger version (140K):
[in this window]
[in a new window]
 
Figure 1. Expression of sialyl residues in murine eosinophil-specific granules with and without enzyme treatment. (A) MAL II lectin staining of eosinophil-specific granules. (B) A higher magnification of A. (C) MAL II lectin staining after pretreatment with Clostridium neuraminidase. Almost no labeling is observed. (D) MAL II lectin staining after pretreatment with keratanase II. Almost no labeling is seen except in cytoplasm. Bars = 0.5 µm.


 
View this table:
[in this window]
[in a new window]
 
Table 2. Quantification of MAL II labeling in eosinophil-specific granulesa

Localization of Sialyl Residues in Eosinophil-specific Granules to Keratan Sulfate
To examine whether sialyl residues are linked to keratan sulfate, the sole proteoglycan that contains sialic acids (Toda and Seno 1970 Down; Choi and Meyer 1975 Down), MAL II lectin staining was performed after treatment with neuraminidase-free keratanase II. As shown in Figure 1D, the enzyme treatment completely eliminated the labeling of MAL II lectin in the specific granules.

HID-TCH-SP-PD staining showed various degrees of positive labeling in crystalloid-free immature granules (Figure 2A), consistent with the pattern of positive labeling with HID-TCH-SP in human and rabbit eosinophil specific granules reported by Parmley et al. 1982 Down. The positive HID-TCH-SP-PD staining was slightly decreased by pretreatment with keratanase (Figure 2B), or keratanase II (not shown). This staining was not completely eliminated but was greatly decreased by pretreatment with chondroitinase ABC specific for chondroitin sulfate and dermatan sulfate (Figure 2C). Finally, staining was completely eliminated by a combination of chondroitinase ABC and keratanase (Figure 2D), or a combination of chondroitinase ABC and keratanase II (not shown). These results suggest that keratan sulfate in the specific granules is of the corneal type (Figure 3), because corneal-type keratan sulfate I is sensitive to both keratanase and keratanase II, whereas keratan sulfate II is sensitive to keratanase II but resistant to keratanase.



View larger version (141K):
[in this window]
[in a new window]
 
Figure 2. Localization of sialyl residues in eosinophil-specific granules with and without enzyme treatment. (A) HID-TCH-SP-PD staining of eosinophil-specific granules. Various degrees of labeling in crystalloid-free immature granules are seen. (B) HID-TCH-SP-PD staining after pretreatment with keratanase. Much labeling is still observed. (C) HID-TCH-SP-PD staining after pretreatment with chondroitinase ABC. Labeling is greatly decreased (D) HID-TCH-SP-PD staining after pretreatment with chondroitinase ABC and keratanase. No labeling is observed. Bar = 0.5 µm.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 3. Carbohydrate structure of keratan sulfates (I and II). Gal, galactose; GlcNAc, N-acetylglucosamine; Man, mannose; Fuc, fucose; Asn, asparagine; NeuAc, sialic acid; Ser, serine; Thr, threonine. From Stuhlsatz et al. 1989 Down, with permission.


*   Discussion
*Top
*Summary
*Introduction
*Materials and Methods
*Results
*Discussion
*Literature Cited

The present studies, using a combination of lectin cytochemistry with MAL II specific for sialyl {alpha}-2,3 galactose residues and enzyme degradation methods, demonstrated that sialyl residues are expressed in eosinophil-specific granules. The sialyl residues were shown to be linked to sulfated proteoglycan using a combination of HID-TCH-SP-PD staining and enzyme degradation. These results confirm the presence of keratan sulfate in eosinophil-specific granules.

The nucleotide sugar CMP-N-acetylneuraminic acid is synthesized in the nucleus (Kean 1991 Down), and glycosylation reactions occur in the lumen of the endoplasmic reticulum and Golgi apparatus (Hirschberg and Snider 1987 Down; Verbert et al. 1987 Down). This explains the difference in MAL II lectin cytochemical staining between pretreatment with neuraminidase and with keratanase II. Neuraminidase was able to eliminate all positive labeling of MAL II in other areas as well as the specific granules, whereas keratanase II eliminated the positive labeling of MAL II that was restricted to specific granules.

Keratan sulfate proteoglycans are classified into two types on the basis of their linkage to protein (Stuhlsatz et al. 1989 Down) (Figure 3). Keratan sulfate I is linked to protein by GlcNAc->asparagine and is found in the cornea (Seno et al. 1965 Down). The second type, keratan sulfate II, is linked to protein by O-glycosidic linkages between N-acetylgalactosamine and serine or threonine, and is found in cartilage and intervertebral disks (Anderson et al. 1964 Down). These two types of keratan sulfate can be distinguished by their sensitivity to keratanase and keratanase II (Nakazawa et al. 1989 Down). Keratan sulfate I is sensitive to both keratanases, whereas keratan sulfate II is sensitive to keratanase II but resistant to keratanase. Keratanase cleaves the internal ß1–4 galactosidic linkages in keratan sulfate and requires at least one N-acetyl-glucosamine 6-sulfate residue adjacent to the galactose residue participating in the galactosidic linkage. Keratanase II cleaves ß1–3 glucosaminidic linkages to galactose, as well as those in keratan sulfates to galactose-6-sulfate (Nakazawa et al. 1989 Down). Keratanase contains a small amount of neuraminidase, but keratanase II is negative for contaminating neuraminidase. We next examined the sensitivity to these two enzymes using HID-TCH-SP-PD staining.

Eosinophil-specific Granules Are Sensitive to Both Keratanase and Keratanase II, Suggesting that They Contain Keratan Sulfate I
The distribution of keratan sulfates and their other functions are not clearly understood. Keratan sulfate I (corneal keratan sulfate) appears to play an important role in maintaining the transparency of the tissue in addition to the common role of proteoglycans, which control the concentration gradient of water in the stroma (Nakazawa et al. 1989 Down). In comparison with keratan sulfate, sialic acids have been analyzed much more extensively. They occur mainly as terminal sugar residues, conferring chemical and biological diversity to glycoconjugates. One of the functions of sialic acids is related to their relatively large hydrophilic and acidic features, which exert physicochemical effects on glycoconjugates and their environment (Schauer et al. 1995 Down). Their other function is in molecular and cellular recognition by masking galactose residues to prevent biological recognition or by making sialyl residues serve as recognition sites (Schauer et al. 1995 Down). Sialyl residues expressed in eosinophil-specific granules may cooperate with sulfated residues in the safe storage of highly basic granule proteins by neutralizing them with their acidity, and enzymes by inactivating their activity.

The present study demonstrated that chondroitinase ABC and keratanase (or keratanase II) are necessary for completely eliminating the positive labeling produced by HID-TCH-SP-PD. Parmley et al. 1982 Down reported that testicular hyaluronidase partially removed the HID-TCH-SP-stained material, and suggested the presence of chondroitin 4- and 6-sulfate and other sulfated glycoconjugates. Metcalfe et al. 1982 Down demonstrated biochemically that the composition of sulfated glycosaminoglycans from human eosinophils was 70–81% chondroitin 4-sulfate, 9–12% chondroitin 6-sulfate, and 5–12% dermatan sulfate. Because chondroitinase ABC is specific for chondroitin sulfate and dermatan sulfate (Oike et al. 1982 Down), the results of the present study are consistent with their findings. Furthermore, we clearly demonstrated that the remaining sulfated GAG in eosinophils is keratan sulfate.

HID-TCH-SP-PD staining showed that murine eosinophil-specific granules have a staining pattern similar to those of human and rabbit, and also can be divided into five developmental stages. Parmley et al. 1982 Down stained human and rabbit developing eosinophils with HID-TCH-SP and divided their specific granules into five developmental stages: precursor granules, labeled in the center of the granule; immature granules Type I, labeled in both the granule center and periphery; immature granules Type II, labeled in the granule perpihery; immature granules Type III, no labeling and lack of a crystalloid core; mature granules, no labeling but a crystalloid core present. Lack of labeling with HID-TCH-SP(-PD) is consistent with the decreased distribution of radiosulfate in mature specific granules (Parmley et al. 1982 Down).

Popken-Harris et al. 1998 Down reported that human eosinophil-specific granules in the process of condensation possess the proform of major basic protein (proMBP) (Barker et al. 1988 Down; McGrogan et al. 1988 Down) around the periphery and have MBP in the central area. The cDNA for MBP encodes a prepromolecule with a total length of 222 amino acids. PreproMBP includes a secretory leader of 15 amino acids, an acidic propiece of 90 amino acids (Shikata et al. 1993 Down; Popken-Harris et al. 1995 Down), and a basic MBP portion of 117 amino acids. The propiece has an estimated pI of 3.9 and confers an overall acidic charge on proMBP. Popken–Harris et al. obtained eosinophils with specific granules by culturing umbilical cord stem cells with interleukin 5. However, the granules were in the process of condensation and did not become the mature specific granules containing a crystalloid core. These authors concluded that the conversion of proMBP to MBP occurs in the granule, and their results support the hypothesis that the propiece of proMBP functions to protect maturing eosinophils from the toxic MBP during granule processing. Furthermore, they pointed out that a lack of HID-TCH-SP labeling in immature granules Type III and mature granules is consistent with the almost total lack of labeling of proMBP in the condensing central area. However, their finding raises the question of whether toxic MBP that loses the propiece in the central area is harmful to specific granules.

The present study demonstrated that, in contrast to HID-TCH-SP-PD staining, sialyl residues are positive in mature specific granules (Figure 1A and Figure 1B) and that their expression is higher in mature than in immature specific granules (Table 2). HID-TCH-SP-PD method detects sulfated residues by forming electrostatic linkage with ionized sulfated residues in the tissue section. Absence of labeling does not always suggest lack of sulfated residues but may also suggest the presence of cationic substances that neutralize the negative charges of sulfated residues. This concept is consistent with the results of low but positive labeling with autoradiography using 35SO42- and lack of labeling with HID-TCH-SP-PD staining in mature granules reported by Parmley et al. 1982 Down. On the other hand, MAL II lectin binds sialyl {alpha}-2,3 galactose residues not with electrostatic strength but with more specific affinity. Therefore, sialyl residues can be detected by MAL II lectin as long as the residues are present in the tissue section. A biochemical study has demonstrated that GAGs may form complexes with lysosomal enzymes and inactivate them (Avila and Convit 1976 Down; Avila 1978 Down). Corresponding findings of masking of acid phosphatase reactivity have been reported in mature eosinophil granules (Wetzel et al. 1967 Down; Bass et al. 1981 Down). The present results of the positive labeling of sialyl residues and the negative labeling of HID-TCH-SP-PD in mature granules also support this concept. Sialyl residues would play a similar role to other sulfated GAGs in specific granules. Therefore, they appear to share with other sulfated GAGs the role of complexing with highly basic granule proteins and inactivating them during the maturation of specific granules. The presence of another acidic GAG, keratan sulfate, suggests that the functions of eosinophil-specific granules are mediated by many substances, including keratan sulfate and other sulfated GAGs.

The sialyl residues can be detected by a MAL II lectin in neutral buffer in contrast to sulfate residues in very acidic buffer, suggesting that the molecules can be isolated without denaturation for further analysis with techniques of molecular biology. Eosinophils play an important role in allergy and inflammatory diseases by releasing their granule proteins. Clarification of the mechanism for safe storage of highly basic granule proteins and their release will help the development of therapy for allergy or eosinophil-related diseases. Analysis focusing on these sialyl molecules will contribute to the purpose.


*   Acknowledgments

Supported in part by the Kodama Foundation for Research in Medical Science.

We wish to thank Mr S. Nonaka for technical assistance and Mr S. Imamura for secretarial assistance.

Received for publication October 1, 1998; accepted November 23, 1998.


*   Literature Cited
*Top
*Summary
*Introduction
*Materials and Methods
*Results
*Discussion
*Literature Cited

Anderson B, Seno N, Sampson P, Riley JG, Hoffman P, Meyer K (1964) Threonine and serine linkages in mucopolysaccharides and glycoproteins. J Biol Chem 239:PC2716-2717[Free Full Text]

Avila JL (1978) The influence of the type of sulphate bond and degree of sulphation of glycosaminoglycans on their interaction with lysosomal enzymes. Biochem J 171:489-491[Medline]

Avila JL, Convit J (1976) Physicochemical characteristics of the glycosaminoglycan-lysosomal enzyme interaction in vitro: a model of control of leucocytic lysosomal activity. Biochem J 160:129-136[Medline]

Barker RL, Gleich GJ, Pease LR (1988) Acidic precursor revealed in human eosinophil granule major basic protein cDNA. J Exp Med 168:1493-1498[Abstract/Free Full Text]

Bass DA, Lewis JC, Szejda P, Cowley L, McCall CE (1981) Activation of lysosomal acid phosphatase of eosinophil leukocytes. Lab Invest 44:403-409[Medline]

Choi HU, Meyer K (1975) The structure of keratan sulphates from various sources. Biochem J 153:543-553

Corfield AP, Veh RW, Wember M, Michalski JC, Schauer R (1981) The release of N-acetyl- and N-glycolloyl-neuraminic acids from soluble complex carbohydrates and erythrocytes by bacterial, viral and mammalian sialidase. Biochem J 197:293-299[Medline]

Dunn WB, Spicer SS (1969) Histochemical demonstration of sulfated mucosubstances and cationic proteins in human granulocytes and platelets. J Histochem Cytochem 17:668-674[Abstract]

Goode NP, Shires M, Aparicio SR, Davison AM (1991) Cationic colloidal gold—a novel marker for the demonstration of glomerular polyanion status in routine renal biopsies. Nephrol Dial Transplant 6:923-930

Hardin JH, Spicer SS (1970) An ultrastructural study of human eosinophil granules: maturational stages and pyroantimonate reactive cation. Am J Anat 128:283-310[Medline]

Hardin JH, Spicer SS (1971) Ultrastructural localization of dialyzed iron-reactive mucosubstance in rabbit heterophils, basophils, and eosinophils. J Cell Biol 48:368-386[Abstract/Free Full Text]

Hirschberg CB, Snider MD (1987) Topography of glycosylation in the rough endoplasmic reticulum and Golgi apparatus. Annu Rev Biochem 56:63-87[Medline]

Ito N, Yokota M, Nagaike C, Morimura Y, Hatake K, Tanaka O, Matsunaga T (1996) Simultaneous expression of keratan sulphate epitope (a sulphated poly-N-acetyllactosamine) and blood group ABH antigens in papillary carcinomas of the human thyroid gland. Histochem J 28:613-623[Medline]

Kean EL (1991) Sialic acid activation. Glycobiology 1:441-447[Abstract/Free Full Text]

McGrogan M, Simonsen C, Scott R, Griffith J, Ellis N, Kennedy J, Campanelli C, Nathan C, Gabay J (1988) Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein. J Exp Med 168:2295-2308[Abstract/Free Full Text]

Metcalfe DD, Litvin J, Wasserman SI (1982) The isolation, identification and characterization of sulfated glycosaminoglycans synthesized in vitro by human eosinophils. Biochim Biophys Acta 715:196-204[Medline]

Murata F, Tsuyama S, Ihida K, Kashio N, Kawano M, Zeng ZL (1992) Sulfated glycoconjugates demonstrated in combination with high iron diaminethiocarbohydrazide-silver proteinate and silver acetate physical development. J Electron Microsc 41:14-20[Abstract/Free Full Text]

Nakazawa K, Ito M, Yamagata T, Suzuki S (1989) Substrate specificity of keratan sulphate-degrading enzymes (endo-ß-galactosidase, keratanase and keratanase II) from microorganisms. In Greiling H, Scott JE, eds. Keratan Sulphate: Chemistry, Biology, Chemical Pathology. London, Biochemical Society, 99-110

Nakazawa K, Suzuki N, Suzuki S (1975) Sequential degradation of keratan sulfate by bacterial enzymes and purification of a sulfatase in the enzymatic system. J Biol Chem 250:905-911[Abstract/Free Full Text]

Oike Y, Kimata K, Shinomura T, Suzuki S, Takahashi N, Tanabe K (1982) A mapping technique for probing the structure of proteoglycan core molecules. J Biol Chem 257:9751-9758[Abstract/Free Full Text]

Parmley RT, Takagi M, Spicer SS, Thrasher A, Denys FR (1982) Ultrastructural visualization of complex carbohydrates in eosinophilic leukocytes. Am J Anat 165:53-67[Medline]

Popken–Harris P, Checkel JL, Loegering DA, Madden B, Springett M, Kephart G, Gleich GJ (1998) Regulation and processing of a precursor form of eosinophil granule major basic protein (ProMBP) in differentiating eosinophils. Blood 92:623-631[Abstract/Free Full Text]

Popken–Harris P, McGrogan M, Loegering DA, Checkel JL, Kubo H, Thomas LL, Moy JN, Sottrup–Jensen L, Snable JL, Kikuchi MT, Gleich GJ (1995) Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein. J Immunol 155:1472-1480[Abstract]

Rosenberg A (1995) Biology of the Sialic Acids. New York, Plenum Press

Roth J, Lucocq JM, Charest PM (1984) Light and electron microscopic demonstration of sialic acid residues with the lectin from Limax flavus: a cytochemical affinity tecnique with the use of fetuin–gold complexes. J Histochem Cytochem 32:1167-1176[Abstract]

Schauer R, Kelm S, Reuter G, Roggentin P, Shaw L (1995) Biochemistry and role of sialic acids. In Rosenberg A, ed. Biology of the Sialic acids. New York, Plenum Press, 7-67

Seno N, Meyer K, Anderson B, Hoffman B (1965) Variations in keratosulfates. J Biol Chem 240:1005-1010[Free Full Text]

Shibuya N, Goldstein IJ, Broekaert WF, Nsimba–Lubaki M, Peeters B, Peumans WJ (1987) The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem 262:1596-1601[Abstract/Free Full Text]

Shikata Y, Hayashi Y, Yoshimatsu K, Ohya Y, Seto T, Fukushima K, Yoshida Y (1993) Pro-major basic protein has three types of sugar chains at the pro-portion. Biochim Biophys Acta 1163:243-249[Medline]

Stuhlsatz HW, Keller R, Becker G, Oeben M, Lennartz L, Fischer DC, Greiling H (1989) Structure of keratan sulphate proteoglycan: core protein, linkage regions, carbohydrate chains. In Greiling H, Scott JE, eds. Keratan Sulphate: Chemistry, Biology, Chemical Pathology. London, Biochemical Society, 1-11

Toda N, Seno N (1970) Sialic acid in the keratan sulfate fraction from whole cartilage. Biochim Biophys Acta 208:227-235[Medline]

Venge P (1993) Human eosinophil granule proteins: structure, function and release. In Smith H, Cook RM, eds. Immunopharmacology of Eosinophils. London, Academic Press, 43-55

Verbert A, Cacan R, Cecchelli R (1987) Membrane transport of sugar donors to the glycosylation sites. Biochimie 69:91-99[Medline]

Wang WC, Cummings RD (1988) The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked alpha-2,3 to penultimate galactose residues. J Biol Chem 254:2786-2792

Wetzel BK, Spicer SS, Horn RG (1967) Fine structural localization of acid alkaline phosphatases in cells of rabbit blood and bone marrow. J Histochem Cytochem 15:311-334[Abstract]

Yang D-H, Tsuyama S, Ohmori J, Murata F (1998) Sulphated glycosaminoglycans in guinea pig eosinophils studied by means of cationic colloidal gold. Histochem J 30:1-6[Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohmori, J.
Right arrow Articles by Murata, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohmori, J.
Right arrow Articles by Murata, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact